The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers

This publication has 22 references indexed in Scilit:

• Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)
  British Journal of Dermatology, 1982
• Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
  Circulation, 1981
• The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease
  Prostaglandins and Medicine, 1981
• Prostacyclin Reversal of Lethal Endotoxemia in Dogs
  Journal of Clinical Investigation, 1981
• PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MAN
  The Lancet, 1981
• Haemodynamic changes induced by prostacyclin in man.
  Heart, 1980
• PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILURE
  The Lancet, 1980
• Salutary Effects of Prostacyclin in Endotoxic Shock
  Pharmacology, 1980
• Effects of prostacyclin (PGI2), 6-oxo-PGF1 alpha and PGE2 on sympathetic nerve function in mesenteric arteries and veins of the rabbit in vitro.
  Hypertension, 1979
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977